REGENXBIO Inc.

Ownership Transactions Reported by 18 Insiders

Symbol
RGNX on Nasdaq
Industry
Biological Products, (No Diagnostic Substances)
Location
9804 Medical Center Drive, Rockville, MD

Insiders trading volume in the past year

REGENXBIO Inc. executives and other stock owners filed with the SEC include:

Name Relationship Holdings Value Past Year Net Change Change % Report Date
Allan M. Fox Director $45.8M May 31, 2024
Curran Simpson Chief Executive Officer, Director $1.99M -$147K -6.87% Jan 2, 2025
Olivier Danos Chief Scientific Officer $1.83M Feb 1, 2025
Kenneth T. Mills Director $1.79M -$653K -26.8% Mar 27, 2025
Steve Pakola Chief Medical Officer $1.7M Feb 1, 2025
Patrick J. Christmas Chief Legal Officer $1.26M Feb 1, 2025
Vittal Vasista Chief Financial Officer $927K Mar 19, 2024
Mitchell Chan Chief Financial Officer $726K Jan 2, 2025
Jennifer Zachary Director $226K May 31, 2024
David C. Stump Director $178K May 31, 2024
George V. Migausky Director $178K May 31, 2024
Jean Bennett Director $178K May 31, 2024
Daniel Tasse Director $178K May 31, 2024
Alexandra Glucksmann Director $178K May 31, 2024
Craig Malzahn Chief Technology Officer $138K Mar 13, 2025
Argeris N. Karabelas Director $114K -$631K -84.7% Oct 1, 2024
Daniel Abdun-Nabi Director Jun 4, 2021
Luke M. Beshar Director Jun 4, 2021

Recent Insider Transactions by Companies or Individuals for REGENXBIO Inc.

Insider Symbol Class Transaction % Value $ * Price $ Shares Shares Owned Date Ownership
* An asterisk sign (*) next to the price indicates that the price is likely invalid.